1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015" provides data on the Muscle Invasive Bladder Cancer (MIBC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Invasive Bladder Cancer (MIBC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Muscle Invasive Bladder Cancer (MIBC) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Muscle Invasive Bladder Cancer (MIBC) 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Celldex Therapeutics, Inc. 31
Clinical Trial Overview of Celldex Therapeutics, Inc. 31
Astellas Pharma Inc. 32
Clinical Trial Overview of Astellas Pharma Inc. 32
Clinical Trial Overview of Top Institutes / Government 33
Memorial Sloan Kettering Cancer Center 33
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 33
Fox Chase Cancer Center 34
Clinical Trial Overview of Fox Chase Cancer Center 34
Trans Tasman Radiation Oncology Group 35
Clinical Trial Overview of Trans Tasman Radiation Oncology Group 35
Brown University 36
Clinical Trial Overview of Brown University 36
Centre Val d'Aurelle - Paul Lamarque 37
Clinical Trial Overview of Centre Val d'Aurelle - Paul Lamarque 37
Nara Medical University 38
Clinical Trial Overview of Nara Medical University 38
Hiroshima University Hospital 39
Clinical Trial Overview of Hiroshima University Hospital 39
Hirosaki University 40
Clinical Trial Overview of Hirosaki University 40
Sun Yat-sen University 41
Clinical Trial Overview of Sun Yat-sen University 41
Tata Memorial Hospital 42
Clinical Trial Overview of Tata Memorial Hospital 42
Five Key Clinical Profiles 43
Appendix 66
Abbreviations 66
Definitions 66
Research Methodology 67
Secondary Research 67
About GlobalData 68
Contact Us 68
Disclaimer 68
Source 69

List of Tables
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celldex Therapeutics, Inc., 2015* 31
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 32
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 33
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2015* 34
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Trans Tasman Radiation Oncology Group, 2015* 35
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brown University, 2015* 36
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Val d'Aurelle - Paul Lamarque, 2015* 37
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Nara Medical University, 2015* 38
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2015* 39
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hirosaki University, 2015* 40
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 41
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tata Memorial Hospital, 2015* 42

List of Figures
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, G7 Countries (%), 2015* 14
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Muscle Invasive Bladder Cancer (MIBC) to Oncology Clinical Trials, E7 Countries (%), 2015* 17
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Muscle Invasive Bladder Cancer (MIBC) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Muscle Invasive Bladder Cancer (MIBC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 67

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.